COREALIS PHARMA
Live / Registered — Registered and renewed (as of 15 Aug 2020)
What this means for you
Registered since 24 May 2011. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 24 May 2021).
Record
- Serial number
- 77902871
- Registration number
- 3964152
- Mark type
- Stylized text
- Filed
- 30 Dec 2009
- Published for opposition
- 08 Mar 2011
- Registered
- 24 May 2011
- Next maintenance due
- 24 May 2021
- Attorney of record
- Jess M. Collen
Goods and services
- Class 040 — Treatment of materials: Custom manufacture of pharmaceutical solid oral drug products sold in capsule, tablet, and granule form
- Class 042 — Scientific and technological services: Research and development in the fields of biotechnology and pharmaceuticals; development of chemical production methods
Owner
- Corealis Pharma Inc., Laval, Quebec, CA
- Corealis Pharma Inc., Laval, Quebec, CA
- Corealis Pharma Inc., 200 Armand-Frappier, CA
Prosecution history
- 15 Aug 2020 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 15 Aug 2020 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 15 Aug 2020 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 13 Aug 2020 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 22 Jun 2020 — TEAS SECTION 8 & 9 RECEIVED
- 24 May 2020 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 20 May 2017 — SEC. 15 ACKNOWLEDGEMENT - E-MAILED
- 20 May 2017 — REGISTERED - SEC. 15 ACKNOWLEDGED
- 18 May 2017 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 16 Feb 2017 — TEAS SECTION 15 RECEIVED
- 12 Jun 2016 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 11 Jun 2016 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
- 11 Jun 2016 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 31 May 2016 — TEAS SECTION 8 RECEIVED
- 31 May 2016 — TEAS CHANGE OF CORRESPONDENCE RECEIVED